|Home | About | Journals | Submit | Contact Us | Français|
Children presenting with wheeze are likely to have either atopic asthma or episodic viral wheeze; distinguishing between these has important implications for management
If it's wheeze it must be asthma, and if it's asthma it must mean bronchodilators and inhaled corticosteroids—simple enough. Indeed, as asthma is so common this paradigm might seem to be logical. The large scale international study of asthma and allergy in childhood (ISAAC) found that the United Kingdom, Australia, and New Zealand had among the highest prevalences, with 15% of children affected.1 Asthma is more complicated, however, especially in children. We are often uncertain whether children who wheeze do have asthma, and some people say that diagnosing asthma in very young children is not possible. An increasing body of evidence suggests that asthma is a complex disorder and that different patterns of illness have different underlying pathogenesis.
Many studies have investigated various treatments in older children with classic allergic asthma, yet relatively few have considered the many young children who have recurrent wheeze. Many common treatments now have a good evidence base, but gaps still exist, such as treatments for the most difficult and severe childhood asthma. Therapeutic advances include both new drugs and new licences for older drugs. For example, the new drug omalizumab and montelukast are now licensed down to 6 months of age. Yet despite an increasing number of therapeutic options, children still die from asthma (23 recorded deaths in 20022). With this in mind, this first of two articles will review the features of the two most common patterns of childhood wheezing illnesses: atopic asthma and episodic viral wheeze. The second review will focus on management.
This review draws on the chapter on asthma and other wheezing disorders in children in Clinical Evidence, search date October 2006. We searched Medline in January 2007 with the terms asthma, viral induced wheeze, childhood, prevalence, symptoms, diagnosis, management, corticosteroids, and adrenal suppression. We also used the British Thoracic Society/Scottish Intercollegiate Guidelines Network guideline on the management of asthma
If one feature consistently points to a diagnosis of asthma, it is wheeze. Wheeze is the end result of narrowing of small airways due to processes that include oedema of the airway wall, contraction of smooth muscle, and mucus plugging. A study of parents of wheezing children found that some thought that wheeze was a sound such as whistling, squeaking, or gasping, whereas others defined it as a different rate, style, or timbre of breathing, and some thought it was the same as coughing.3 This is an important reminder that reported wheeze might not be wheezing after all. Associated with asthmatic wheeze is the observation of variable or reversible airways obstruction.4 Over the 1980s, however, with an increased recognition of allergy, “asthma” became synonymous with “atopic asthma.” For many people, asthma became wheeze plus allergy plus bronchial hyper-responsiveness.5 However, this approach failed to recognise those young children and indeed older children and adults who wheeze only with colds,6 7 strongly suggesting more than one phenotype of wheezing illnesses.
The most widely recognised phenotype of wheeze is atopic asthma. This commonly presents as the school aged child who complains of episodic wheeze, cough, and shortness of breath, often with identifiable triggers and other signs of atopy, such as eczema and hay fever. Atopic asthma is more common than non-atopic childhood asthma; as many as 85% of school aged children with asthma are atopic.8 This type of asthma is classically associated with eosinophils and mast cells. Many studies have identified these cells in bronchial tissues and secretions of people with asthma. Increased numbers of eosinophils are known to be associated with increased symptoms of asthma, and using eosinophils as a guide to adjusting corticosteroid treatment has been shown to be an effective strategy for treating asthma in adults.9
One area of diagnostic difficulty in childhood asthma is chronic cough. Cough is a common complaint in childhood; up to 10% of preschool and early school aged children have chronic cough without wheeze at some time.10 Although childhood asthma may present with cough, most children who cough without wheeze do not have asthma (box 1). Isolated chronic cough is a poor marker of asthma and, without other typical features of asthma, should always raise the strong possibility of an alternative cause.9 However, cough predominant or cough variant asthma undoubtedly exists, possibly because sometimes wheeze is not easily identified. It is associated with bronchial hyper-responsiveness or reversible airways obstruction, both key features of asthma.11 Demonstrating these features can help to identify children with cough predominant asthma. In the absence of these features, a short trial of asthma treatment may aid the diagnosis of asthma.12 Establishing that improvement in cough is due to treatment rather than coincidence is, however, important, as postviral cough will spontaneously improve. A return of symptoms on discontinuing treatment supports asthma as the diagnosis.
Before the 1980s, wheezy and “chesty” young children were commonly referred to as “wheezy bronchitics.”13 This describes an illness triggered by the common cold and leading to mucous hypersecretion, inflammation, and bronchoconstriction. Wheezy, rattling children are a common phenotype that we recognise as different from children with atopic asthma: so called “episodic viral wheezers.” These children are not considered truly asthmatic and are not included in most studies of the epidemiology of asthma. However, their acute episodes are similar to those of older children labelled as having asthma. Episodic viral wheeze is common; 30-50% of preschool children have at least one episode. Some young children with atopic asthma start with a pattern of episodic viral wheeze before more persistent features surface, but most of those with pure episodic viral wheeze tend to outgrow their symptoms as they get older. Emerging data on pathophysiology support this as a distinct phenotype. One reason why these children wheeze with viruses is likely to be that they are born with smaller airway dimensions than those who do not wheeze.8 In one study, bronchoalveolar lavages were taken from asymptomatic preschool children with atopic asthma, those with episodic viral wheeze, and healthy controls having routine surgery.14 Those with atopic asthma had increased numbers of eosinophils and mast cells compared with episodic viral wheezers, who were similar to controls. An experimental viral infection of adults with episodic viral wheeze showed a predominantly neutrophilic inflammatory response without any evidence of eosinophilia.15 This pattern of neutrophil activation has also been shown in children with episodic viral wheeze.16 The link between inflammation and wheeze, however, is likely to be complex; evidence from the same group indicates that eosinophils may play a role in episodic viral wheeze independent of atopy.17
Much remains to be understood about the interaction between viruses and wheezing episodes. Viruses are the major trigger for acute asthma attacks in children and adults. We know that respiratory syncytial virus infection is associated with recurrent wheezing for several months and occasionally years after bronchiolitis. Emerging evidence indicates that subtle differences in the responses of the innate and adaptive immune systems might be responsible for the development of virus associated wheeze.18 For example, some people with asthma have a reduced interferon γ response to rhinovirus, suggesting a predisposition to viral infection, whereas others have a heightened response with reduced symptoms during colds. A better understanding of why some children wheeze only with viruses and others wheeze with many triggers may one day allow us to target treatments more effectively.
Other conditions can sometimes cause a wheezy chest (table(table).). These should be considered in children who do not display key features of asthma, have additional clinical features (table(table),), or do not respond to conventional asthma treatment.
As with most initial assessments, diagnosis and management are informed by identifying recognised patterns in the history and assessing the severity with additional information gained from the physical examination. Mapping the pattern over time (fig 11)) is useful not only in making a diagnosis but also in assessing severity and guiding treatment. Box 2 provides a guide to history taking and examination.
*Very frequent episodes indicate that day to day control may not be adequate and identify a very vulnerable group of children
If the child does not respond to initial treatment or needs high doses, some specific tests may help to secure the diagnosis and assess severity more objectively.
Peak expiratory flow monitoring—Usually used in children over 5 years, peak expiratory flow monitoring is useful to establish diurnal variation and the severity of obstruction. Routine measurement is likely to be of limited value, with a significant drop-off in reliability of recordings made over long periods of time.19 Normal peak expiratory flow values vary widely, so each child should use his or her “personal best” as a guide to how obstructed they are. Consider using peak expiratory flow monitoring in short bursts, especially when treatment is being changed.
Allergy testing—This is not necessary in routine practice. However, where features are atypical or simple treatments are not working, it may help to establish the presence of atopy and identify specific aeroallergens. Measuring total serum IgE can help to establish atopy as part of the phenotype and, for the most severely affected patients, identify those who might respond to the monoclonal anti-IgE antibody, omalizumab. Skin prick testing with house dust mites, grass pollens, and cat dander will identify atopy in the vast majority of children with asthma. Much evidence exists to link exposure to allergens with symptoms of asthma, but avoidance as a therapeutic option remains controversial. Two Cochrane reviews of avoidance found no evidence of benefit; one was a review of house dust mites (49 trials with 2733 patients),20 and the other was a review of air filtration against cat allergen (two trials with 57 patients).21 Despite this, many experts in the field as well as the British Thoracic Society/Scottish Intercollegiate Guidelines Network guideline recommend avoidance. For committed families with evidence of house dust mite allergy, avoidance measures such as barrier bed covers may be tried,22 and the removal of pets from the home may be tried if the asthmatic child is allergic to that pet.
Pulmonary function tests—Forced spirometry (usually in children over 5 years) can assess airways obstruction (reduced forced expiratory volume in one second and ratio of forced expiratory volume in one second to forced vital capacity; reduced mid-expiratory flows). If obstruction is present, reversibility can be assessed 10 minutes after inhalation of a bronchodilator. If reversibility is absent (that is, less than 15% change in lung function occurs after use of bronchodilator), specific “challenges,” such as exercise and histamine challenges, can be done in a specialist lung function laboratory. These assess bronchial hyper-responsiveness and are believed to have a high negative predictive value for asthma (86-100%), but they are less useful as a positive predictive tool (perhaps as low as 55%), as many children without asthma have bronchial hyper-responsiveness.23
Chest radiography—This is rarely helpful in acute asthma, except where air leaks are suspected. It may be useful when a diagnosis other than asthma is suspected.
Other tests—When the diagnosis is in doubt or where severe asthma persists despite common treatments, referral to a specialist clinic is needed. A few patients need specialised lung function tests, bronchoscopy, or computed tomography scanning to rule out other conditions (table(table).
Different phenotypes of wheeze are seen in childhood. With the approach set out in this review a child can usually be determined to have atopic asthma, non-atopic asthma, or episodic viral wheeze; with an episodic pattern, persistent features, or both; and with a mild, moderate, or severe pattern. This should help to guide the physician in tailoring treatment to suit the individual child. More detailed guidance on points in the history, examination and investigations that aid diagnosis can be found in the British Thoracic Society/Scottish Intercollegiate Guidelines Network guideline.22
Contributors: All authors contributed to the collection of data and to the text of the paper. MM is the guarantor.
Competing interests: None declared.
Provenance and peer review: Commissioned; externally peer reviewed.